Screening method, device and kit for detecting mucosal carbohydrates and associated conditions
OwnerAbulKalam Mohammed Shamsuddininventor
Life of this patent
Estimating the term…
Abstract
This disclosure relates to a screening test method, device, and kit for mucosal carbohydrates and associated conditions including, cancerous and precancerous conditions. Specifically, the method tests abnormal carbohydrates in mucus or body fluid using reagents of galactose oxidase, and Schiff's Reagent. The screening test method, device, and kit provides improved accuracy, and minimizes handling procedures. This disclosure further relates to the use of the device or kit in a medical facility for an initial evaluation for cancerous and precancerous conditions.
Claims24
A screening device for rapidly testing a human being for expression of a mucosal carbohydrate comprising
- a test strip or membrane with galactose oxidase pre-embedded, and
- a container with Schiff reagent solution,
- wherein the Schiff reagent solution is not initially in contact with the test strip or membrane, and the Schiff reagent solution can be activated to contact the test strip or membrane after marker carbohydrates are oxidized by galactose oxidase.
A screening device for rapidly testing a human being for a cancerous or precancerous condition comprising
- a test strip or membrane with galactose oxidase pre-embedded, and
- a container with Schiff reagent solution,
- wherein the Schiff reagent solution is not initially in contact with the test strip or membrane, and the Schiff reagent solution can be activated to contact the test strip or membrane after marker carbohydrates are oxidized by galactose oxidase.
A screening method for rapidly testing a human being for expression of a mucosal carbohydrate comprising:
- applying mucus or body fluid to a test strip or membrane with galactose oxidase pre-embedded,
- oxidizing marker carbohydrates in the mucus or body fluid by reacting with galactose oxidase, and
- activating a container with Schiff reagent solution adjacent to the test strip or membrane to contact the test strip or membrane,
- wherein the Schiff reagent solution is not initially in contact with the test strip or membrane.
A screening method for rapidly testing a human being for a cancerous or precancerous condition comprising
- applying mucus or body fluid to a test strip or membrane with galactose oxidase pre-embedded,
- oxidizing marker carbohydrates in the mucus or body fluid by reacting with galactose oxidase, and
- activating a container with Schiff reagent solution adjacent to the test strip or membrane to contact the test strip or membrane,
- wherein the mucus or body fluid contains marker carbohydrates;
- the Schiff reagent solution is not initially in contact with the test strip or membrane.
A screening kit for rapidly testing a human being for expression of a mucosal carbohydrate comprising
- a test strip or membrane with galactose oxidase pre-embedded, and
- a container with Schiff reagent solution.
A screening kit for rapidly testing a human being for a cancerous or precancerous condition comprising
- a test strip or membrane with galactose oxidase pre-embedded, and
- a container with Schiff reagent solution.
Dependencies are inferred from the claim text.